Metagenomi, Inc. Common Stock
MGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $55 | $50 | $134 |
| - Cash | $33 | $27 | $29 | $27 |
| + Debt | $36 | $43 | $44 | $46 |
| Enterprise Value | – | $71 | $66 | $152 |
| Revenue | $9 | $9 | $4 | $10 |
| % Growth | 1.7% | 106.3% | -57.1% | – |
| Gross Profit | $7 | -$14 | $4 | $10 |
| % Margin | 84.7% | -164.4% | 100% | 100% |
| EBITDA | -$19 | -$20 | -$26 | -$19 |
| % Margin | -222.9% | -230.8% | -641.2% | -199.3% |
| Net Income | -$20 | -$20 | -$25 | -$23 |
| % Margin | -235.5% | -233.9% | -606.7% | -243.4% |
| EPS Diluted | -0.55 | -0.54 | -0.68 | -0.63 |
| % Growth | -1.9% | 20.6% | -7.9% | – |
| Operating Cash Flow | -$21 | -$21 | -$23 | -$26 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$21 | -$21 | -$23 | -$27 |